Breast Cancer Trial, Recruiting NCT07539038 Sponsor: Centro di Riferimento Oncologico - Aviano Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07539038
Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People diagnosed with early-stage (Stage I to IIIa) breast cancer that is hormone receptor-positive, who are currently receiving hormonal therapy after their main treatment
  • Women aged 18 or older
  • People who are willing and able to sign a consent form before any study activities begin
  • People who are taking part in the "Medicina and Sport" physical activity program run by Andos Pordenone

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People with early-stage breast cancer where the tumour tested negative for hormone receptors
  • People with hormone receptor-positive early-stage breast cancer who are currently receiving chemotherapy
  • People whose breast cancer has spread to other parts of the body or is at an advanced stage
  • People currently receiving active treatment for another type of cancer (not including a common type of skin cancer called basal cell carcinoma, or very early-stage cancers that have not spread)
  • People who have had a history of bone fractures in the spine or hip
  • People with heart or blood vessel conditions that are not well managed with their current medications (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0434659092

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centro di Riferimento Oncologico - Aviano
Registry
ClinicalTrials.gov
Start date
3 April 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Change in Quality of Life as measured by the EORTC QLQ-C30 questionnaire.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov